Clinical Trial Update: Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH) [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating microbiota transfer or placebo after antimicrobial therapy for recurrent Clostridium difficile infection was terminated; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridium Difficile Infection

Snippet

Sponsor: VA Office of Research and Development | Conditions: Clostridium Difficile Infection | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2023-10-11